Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition

Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc. (NASDAQ:GH) completed the acquisition of the health technology company MetaSight Diagnostics. The $149 million acquisition comes as the company gears up for revenue growth in 2026. Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition With the acquisition, Guardant Health is to gain access to a range of next-generation liquid biopsies ...